If continued assistance is needed beyond that, youll need to reapply annually and provide updated documentation to confirm ongoing eligibility
Key weight loss results at 48 weeks by group: Response rates at 48 weeks (12 mg dose): 100% achieved greater than or equal to 5% weight loss 93% achieved greater than or equal to 10% weight loss 83% achieved greater than or equal to 15% weight loss The cardiometabolic improvements were also significant, with reductions in blood pressure, triglycerides, LDL cholesterol, HbA1c, fasting glucose, and fasting insulin across all dose groups
The consequences sit elsewhere
Titration Schedules Importance of Titration Jumping straight to 8mg or 12mg would cause severe nausea and vomiting for most people
EMA Decision P/0336/2024 Paediatric Investigation Plan for Retatrutide
The peer-reviewed study, published in Obesity , showed that patients getting care through Ro's platform were able to achieve weight loss outcomes and a safety profile consistent with clinical trials conducted by Novo Nordisk
